ATLANTA, March 17 -- The American College of Rheumatology (ACR) has released an official position statement concerning prior authorization for the approval of prescription medications, highlighting the significant burdens it creates for patients and rheumatology professionals. This process can result in a significant delay of care or treatments, treatment abandonment and potential harm to patients.
"In addition to creating additional hoops for patients and providers to jump through, prior authorization diverts valuable time away from caring for patients and towards repetitive and time-consuming administrative tasks." said Virginia Reddy, MD the statement's lead author and member of the ACR's Committee on Rheumatologic Care (CORC). "For pat...